glp 1 agonist therapy GLP-1 receptor agonists GLP-1 Personalized Treatment for Weight
Description
Contemp Clin Trials
Samson SL, Vellanki P, Blonde L, et al
H., Santos, L
GLP- 1 Receptor Agonists for the Treatment of Obesity Liraglutide Liraglutide at a high dose of 3 mg daily is approved for long-term weight control in adults and children over the age of 12 with obesity or overweight plus at least one weight-related comorbidity
GLP-1 and GIP receptor signaling in beta cells A review of receptor interactions and co-stimulation
Lancet 398 (10295), 143155
